Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Neurochemistry of Consciousness
  • Language: en
  • Pages: 366

Neurochemistry of Consciousness

This pioneering book explores in depth the role of neurotransmitters in conscious awareness. The central aim is to identify common neural denominators of conscious awareness, informed by the neurochemistry of natural, drug induced and pathological states of consciousness. Chemicals such as acetylcholine and dopamine, which bridge the synaptic gap between neurones, are the 'neurotransmitters in mind' that form the substance of the volume, which is essential reading for all who believe that unravelling mechanisms of consciousness must include these vital systems of the brain.Up-to-date information is provided on: • Psychological domains of attention, motivation, memory, sleep and dreaming that define normal states of consciousness. • Effects of chemicals that alter or abolish consciousness, including hallucinogens and anaesthetics. • Disorders of the brain such as dementia, schizophrenia and depression considered from the novel perspective of the way these affect consciousness, and how this might relate to disturbances in neurotransmission. (Series B)

Mental and Behavioral Dysfunction in Movement Disorders
  • Language: en
  • Pages: 554

Mental and Behavioral Dysfunction in Movement Disorders

A state-of-the-art review of the many cognitive, affective, and behavioral dysfunctions associated with movement disorders. These dysfunctions include depression, dementia, psychosis, sleep disorders arising from Parkinson's and Huntington's disease, Tourette's syndrome, as well as multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, and many other related disorders. The authors describe these behavioral syndromes and their neurophysiological and neuropathological substratum, as well as their diagnostic criteria and therapeutic guidelines. The cognitive and affective dysfunctions are spelled out in detail.

Alzheimer Disease
  • Language: en
  • Pages: 571

Alzheimer Disease

None

Neurobiology of Mental Illness
  • Language: en
  • Pages: 1267

Neurobiology of Mental Illness

The new edition of this definitive textbook reflects the continuing reintegration of psychiatry into the mainstream of biomedical science. The research tools that are transforming other branches of medicine - epidemiology, genetics, molecular biology, imaging, and medicinal chemistry - are also transforming psychiatry. The field stands poised to make dramatic advances in defining disease pathogenesis, developing diagnostic methods capable of identifying specific and valid disease entities, discovering novel and more effective treatments, and ultimately preventing psychiatric disorders. The Neurobiology of Mental Illness is written by world-renowned experts in basic neuroscience and the patho...

Mapping the Progress of Alzheimer’s and Parkinson’s Disease
  • Language: en
  • Pages: 596

Mapping the Progress of Alzheimer’s and Parkinson’s Disease

1h The 5 International Conference on the Progress in Alzheimer's Disease and Parkinson's 51 1 Disease took place from March 31 to April 5 \ 2001 in Kroto, Japan. This international 1 conference was organized as a joint Congress with the 9 International Catecholamine Symposium. A total of 1258 clinicians and researchers participated in this joint congress 1h from 38 countries in the world. This book represents the proceedings of the 5 Conference on Alzheimer's and Parkinson's disease. The International Conference on the Progress in Alzheimer's and Parkinson's disease was first launched by Professor Abraham Fisher of Israel and Professor Israel Hanin of USA. The first conference was held in Ei...

Progress in Alzheimer’s and Parkinson’s Diseases
  • Language: en
  • Pages: 846

Progress in Alzheimer’s and Parkinson’s Diseases

This book represents the fourth ina series of international conferences related to Alzheimer's (AD) and Parkinson's (PO) diseases. The first one took place in EHat, Israel in 1985; the second in Kyoto, Japan, in 1989; and the third in Chicago, IL, USA in 1993. This book incorporates the proceedings of the Fourth International Conference on Pro gress in Alzheimer's and Parkinson's Diseases, held in EHat, Israel, on May 18-23, 1997. This Conference was the 41st in the series of annual OHOLO Conferences sponsored by the Israel Institute for Biological Research (IIBR). It was also conducted under the aus pices of the Alzheimer's Association Ronald and Nancy Reagan Research Institute, USA. The Co...

The New Testosterone Treatment
  • Language: en
  • Pages: 388

The New Testosterone Treatment

Written by the leading authority on hormone receptors and prostate cancer, this book reveals the surprising truth about how you can prevent and treat breast cancer, prostate cancer, and Alzheimer's with testosterone and other FDA-approved drugs.For decades, doctors have sought to combat prostate cancer under the mistaken assumption that testosterone fueled its growth. But the latest research into the nature of hormone receptors and therapies using bioidentical instead of synthetic hormones have caused a shift in thinking and new hope for treating this cancer with testosterone. Today the medical profession equates a diagnosis of Alzheimer's with a death sentence. In fact, the only thing docto...

The Alzheimer Conundrum
  • Language: en
  • Pages: 328

The Alzheimer Conundrum

Why our approaches to Alzheimer's and dementia are problematic and contradictory Due to rapidly aging populations, the number of people worldwide experiencing dementia is increasing, and the projections are grim. Despite billions of dollars invested in medical research, no effective treatment has been discovered for Alzheimer's disease, the most common form of dementia. The Alzheimer Conundrum exposes the predicaments embedded in current efforts to slow down or halt Alzheimer’s disease through early detection of pre-symptomatic biological changes in healthy individuals. Based on a meticulous account of the history of Alzheimer’s disease and extensive in-depth interviews, Margaret Lock highlights the limitations and the dissent associated with biomarker detection. Lock argues that basic research must continue, but should be complemented by a public health approach to prevention that is economically feasible, more humane, and much more effective globally than one exclusively focused on an increasingly harried search for a cure.

The Neurochemical Basis of Autism
  • Language: en
  • Pages: 300

The Neurochemical Basis of Autism

A perceived rise in autism worldwide has led to a dramatic increase in autism research. This is a uniquely interdisciplinary text that presents the latest findings regarding the physiological, neuropathological, neurochemical and clinical elements of autism.

Dementia and Normal Aging
  • Language: en
  • Pages: 596

Dementia and Normal Aging

Age has been identified as the strongest risk factor for Alzheimer's disease, and is also strongly associated with vascular dementia. With this relationship in mind, this book looks upon the challenge of dementia as establishing its true relationship with normal aging. The traditional disease model of dementia may have obscured important clues about many underlying causes and features of dementia. In this book, experts and pioneers in the fields of aging and dementia make an important contribution to the understanding of dementia by reappraising the latest research in the light of the continuum model. Evidence for and against numerous models of dementia are discussed with particular relevance to the relationship between Alzheimer's and normal aging. Ranging from molecular genetics and fundamental neurobiology to issues of diagnosis and the provision of services, this is a challenging work in its breadth and level of argument, which has far reaching implications for the study of dementia, and indeed of the mind itself. As a review of current thinking and research it will serve as an essential text for clinicians and scientific investigators.